Terms: = Liver cancer AND CLIP1, ENSG00000130779, 6249, P30622, RSN, MGC131604, CYLN1, CLIP170, CLIP-170, CLIP AND Staging
135 results:
1. Advances in post-operative prognostic models for hepatocellular carcinoma.
He Z; She X; Liu Z; Gao X; Lu LU; Huang J; Lu C; Lin Y; Liang R; Ye J
J Zhejiang Univ Sci B; 2023 Mar; 24(3):191-206. PubMed ID: 36915996
[TBL] [Abstract] [Full Text] [Related]
2. Prospective validation of the Eastern staging in predicting survival after surgical resection for patients with hepatocellular carcinoma: a multicenter study from China.
Yang SC; Liang L; Wang MD; Wang XM; Gu LH; Lin KY; Zhou YH; Chen TH; Gu WM; Li J; Wang H; Chen Z; Li C; Yao LQ; Diao YK; Sun LY; Zhang CW; Zeng YY; Lau WY; Huang DS; Shen F; Yang T
HPB (Oxford); 2023 Jan; 25(1):81-90. PubMed ID: 36167767
[TBL] [Abstract] [Full Text] [Related]
3. Hepatocellular carcinoma patients with portal vein thrombosis treated with robotic radiosurgery: Interim results of a prospective study.
Dutta D; Tatineni T; Yarlagadda S; Gupte A; Reddy SK; Madhavan R; Nair H; Sasidharan A; Kannan R; Pottayil SG; Holla R; Sudhindran S
Indian J Gastroenterol; 2021 Aug; 40(4):389-401. PubMed ID: 34694581
[TBL] [Abstract] [Full Text] [Related]
4. Systematic review and meta-analysis of validated prognostic models for resected hepatocellular carcinoma patients.
Beumer BR; Buettner S; Galjart B; van Vugt JLA; de Man RA; IJzermans JNM; Koerkamp BG
Eur J Surg Oncol; 2022 Mar; 48(3):492-499. PubMed ID: 34602315
[TBL] [Abstract] [Full Text] [Related]
5. HMGCS2 in metabolic pathways was associated with overall survival in hepatocellular carcinoma: A LASSO-derived study.
Ding R; Chen T; Zhang Y; Chen X; Zhuang L; Yang Z
Sci Prog; 2021; 104(3):368504211031749. PubMed ID: 34260294
[TBL] [Abstract] [Full Text] [Related]
6. Hepatic Arterial Infusion Chemotherapy with Modified FOLFOX as an Alternative Treatment Option in Advanced Hepatocellular Carcinoma Patients with Failed or Unsuitability for Transarterial Chemoembolization.
Hsu SJ; Xu X; Chen MP; Zhao ZY; Wang Y; Yin X; Zhang L; Ge NL; Chen Y; Wang YH; Luo JF; Ren ZG; Chen RX
Acad Radiol; 2021 Nov; 28 Suppl 1():S157-S166. PubMed ID: 33653656
[TBL] [Abstract] [Full Text] [Related]
7. Comparison of prognostic models in advanced hepatocellular carcinoma patients undergoing Sorafenib: A multicenter study.
Marasco G; Colecchia A; Bacchi Reggiani ML; Celsa C; Farinati F; Giannini EG; Benevento F; Rapaccini GL; Caturelli E; Di Marco M; Biasini E; Marra F; Morisco F; Foschi FG; Zoli M; Gasbarrini A; Baroni GS; Masotto A; Sacco R; Raimondo G; Azzaroli F; Mega A; Vidili G; Brunetto MR; Nardone G; Dajti E; Ravaioli F; Avanzato F; Festi D; Trevisani F;
Dig Liver Dis; 2021 Aug; 53(8):1011-1019. PubMed ID: 33353858
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic evaluation of HCC patients undergoing surgical resection: an analysis of 8 different staging systems.
Bednarsch J; Czigany Z; Heise D; Joechle K; Luedde T; Heij L; Bruners P; Ulmer TF; Neumann UP; Lang SA
Langenbecks Arch Surg; 2021 Feb; 406(1):75-86. PubMed ID: 33294952
[TBL] [Abstract] [Full Text] [Related]
9. HCC-Mark: a simple non-invasive model based on routine parameters for predicting hepatitis C virus related hepatocellular carcinoma.
Omar M; Farid K; Emran T; El-Taweel F; Tabll A; Omran M
Br J Biomed Sci; 2021 Apr; 78(2):72-77. PubMed ID: 33016838
[TBL] [Abstract] [Full Text] [Related]
10. Integrating baseline MR imaging biomarkers into BCLC and clip improves overall survival prediction of patients with hepatocellular carcinoma (HCC).
Aliyari Ghasabeh M; Shaghaghi M; Pandey A; Ameli S; Ambale Venkatesh B; Jacob A; Pandey P; Hazhirkarzar B; Luo Y; Rezvani Habibabadi R; Khoshpouri P; Ghadimi M; Kamel IR
Eur Radiol; 2021 Mar; 31(3):1630-1641. PubMed ID: 32910233
[TBL] [Abstract] [Full Text] [Related]
11. [Retrospective investigation of patients receiving additional surgery after endoscopic non-curative resection for early colorectal cancer].
Sun YM; Zhang DS; Feng YF; Wang Y; Xu ZW
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 May; 23(5):486-491. PubMed ID: 32842429
[No Abstract] [Full Text] [Related]
12. Toll-like receptor 7 mRNA is reduced in hepatitis C-based liver cirrhosis and hepatocellular carcinoma, out-performs alpha-fetoprotein levels, and with age and serum aspartate aminotransferase is a new diagnostic index.
Mohamed AA; Omran D; El-Feky S; Darwish H; Kassas A; Farouk A; Ezzat O; Abdo SM; Zahran FE; El-Demery A; Omran MM
Br J Biomed Sci; 2021 Jan; 78(1):18-22. PubMed ID: 32573389
[TBL] [Abstract] [Full Text] [Related]
13. Development and Validation of a Nomogram-Based Prognostic Evaluation Model for Sarcomatoid Hepatocellular Carcinoma.
Ge D; Luo Z; Mao R; Zhao H; Lv X; Zhao J; Zhou J; Huang Z; Zhang Y; Li Z; Bi X; Cai J
Adv Ther; 2020 Jul; 37(7):3185-3205. PubMed ID: 32436026
[TBL] [Abstract] [Full Text] [Related]
14. Evolution of etiology, presentation, management and prognostic tool in hepatocellular carcinoma.
Ho SY; Liu PH; Hsu CY; Hsia CY; Huang YH; Lei HJ; Su CW; Lee RC; Hou MC; Huo TI
Sci Rep; 2020 Mar; 10(1):3925. PubMed ID: 32127619
[TBL] [Abstract] [Full Text] [Related]
15. A combination of α-fetoprotein, midkine, thioredoxin and a metabolite for predicting hepatocellular carcinoma.
Omran MM; Farid K; Omar MA; Emran TM; El-Taweel FM; Tabll AA
Ann Hepatol; 2020; 19(2):179-185. PubMed ID: 31648804
[TBL] [Abstract] [Full Text] [Related]
16. Comparison of 10 prognostic staging systems in patients with advanced hepatocellular carcinoma.
Wang L; Xian Y; Yang Z
J BUON; 2019; 24(1):150-157. PubMed ID: 30941964
[TBL] [Abstract] [Full Text] [Related]
17. Using natural language processing to extract clinically useful information from Chinese electronic medical records.
Chen L; Song L; Shao Y; Li D; Ding K
Int J Med Inform; 2019 Apr; 124():6-12. PubMed ID: 30784428
[TBL] [Abstract] [Full Text] [Related]
18. staging systems of hepatocellular carcinoma: A review.
Tellapuri S; Sutphin PD; Beg MS; Singal AG; Kalva SP
Indian J Gastroenterol; 2018 Nov; 37(6):481-491. PubMed ID: 30593649
[TBL] [Abstract] [Full Text] [Related]
19. The Munich-Transarterial Chemoembolisation Score Holds Superior Prognostic Capacities Compared to TACE-Tailored Modifications of 9 Established staging Systems for Hepatocellular Carcinoma.
Op den Winkel M; Nagel D; Op den Winkel P; Paprottka PM; Schmidt L; Bourhis H; Trojan J; Goeller M; Reiter FP; Stecher SS; De Toni EN; Gerbes AL; Kolligs FT
Digestion; 2019; 100(1):15-26. PubMed ID: 30282074
[TBL] [Abstract] [Full Text] [Related]
20. A nomogram integrating hepatic reserve and tumor characteristics for hepatocellular carcinoma following curative liver resection.
Cai BB; Shi KQ; Li P; Chen BC; Shi L; Johnson PJ; Lai P; Toyoda H; Zhou MT
Clin Chim Acta; 2018 Oct; 485():187-194. PubMed ID: 29908940
[TBL] [Abstract] [Full Text] [Related]
[Next]
